Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Hemophilia A”

Showing 20 of 0 results

Not applicableUnknownNCT01538160
What this trial is testing

A Single and Low Dose of Recombinant Factor VIIa in Patients With Severe Factor XI Deficiency Undergoing Surgery

Who this might be right for
Hemophilia C
Sheba Medical Center 15
Large-scale testing (Phase 3)Study completedNCT02234323
What this trial is testing

An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia A

Who this might be right for
Hemophilia A
Bioverativ, a Sanofi company 108
Not applicableEnrolling By InvitationNCT06816953
What this trial is testing

Cartilage Biomarkers and HEAD-US Score in Severe Hemophilia A Patients Receiving FVIII Prophylaxis

Who this might be right for
Hemophilia A
Chulalongkorn University 19
Not applicableStudy completedNCT04876365
What this trial is testing

A Study in Children, Teenagers and Adults With Severe Hemophilia A Who Switched From Other Factor VIII Treatments to Adynovate

Who this might be right for
Hemophilia A
Takeda 153
Large-scale testing (Phase 3)Study completedNCT03587116
What this trial is testing

Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

Who this might be right for
Hemophilia BHemophilia A
Pfizer 212
Post-approval studies (Phase 4)Study completedNCT04396639
What this trial is testing

Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Hemophilia A Patients

Who this might be right for
Hemophilia A
Pfizer 50
Not applicableStudy completedNCT04953000
What this trial is testing

Standard and Individualized Prophylactic Treatment With Advate in Men and Boys With Severe Hemophilia A

Who this might be right for
Hemophilia A
Takeda 94
Large-scale testing (Phase 3)Study completedNCT01580293
What this trial is testing

A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A

Who this might be right for
Hemophilia A
Bayer 145
Testing effectiveness (Phase 2)Study completedNCT05421429
What this trial is testing

KN057 Multiple Dose Study in Moderately Severe to Severe Hemophilia

Who this might be right for
Hemophilia
Suzhou Alphamab Co., Ltd. 24
Large-scale testing (Phase 3)UnknownNCT01619046
What this trial is testing

Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A

Who this might be right for
Hemophilia A
Green Cross Corporation 124
Testing effectiveness (Phase 2)Ended earlyNCT05789524
What this trial is testing

The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia aHemophilia B
ApcinteX Ltd 60
Not applicableStudy completedNCT05279924
What this trial is testing

Outcomes of Prophylaxis With Emicizumab in Children With Severe Hemophilia A in Ivory Coast

Who this might be right for
Hemophilia A
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 33
Not applicableStudy completedNCT04181697
What this trial is testing

HemFitBit, an Observational Study of Physical Activity in People With Moderate and Severe Haemophilia A

Who this might be right for
Hemophilia A Without Inhibitor
Oslo University Hospital 40
Early research (Phase 1)Study completedNCT01579903
What this trial is testing

Relative Bioavailability Of Two Formulations Of Moroctocog Alfa (AF-CC)

Who this might be right for
Hemophilia A
Pfizer 16
Large-scale testing (Phase 3)Looking for participantsNCT05611801
What this trial is testing

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 100
Early research (Phase 1)Study completedNCT05265767
What this trial is testing

Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A

Who this might be right for
Hemophilia A
Christian Medical College, Vellore, India 6
Early research (Phase 1)Study completedNCT04864743
What this trial is testing

Evaluate the Pharmacokinetics，Safety and Tolerability of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection

Who this might be right for
Severe Hemophilia A
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 13
Testing effectiveness (Phase 2)Study completedNCT00717626
What this trial is testing

Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A

Who this might be right for
Hemophilia A
The Hospital for Sick Children 14
Post-approval studies (Phase 4)Study completedNCT00666406
What this trial is testing

Pharmacokinetic Comparison of Advate rAHF-PFM With Recombinate rAHF in Patients With Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 9
Large-scale testing (Phase 3)Study completedNCT00037544
What this trial is testing

Study Evaluating ReFacto AF in Severe Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation